EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The identification of matrix Gla protein in cartilage



The identification of matrix Gla protein in cartilage



Journal of Biological Chemistry 263(12): 5820-5824



The vitamin K-dependent bone protein matrix .gamma.-carboxyglutamic acid (Gla) protein (MGP) has been identified by radioimmunoassy in the guanidine extract of rat cartilage. MGP was present in all cartilages tested at levels comparable to the MGP level in bone. Western blot analysis indicated that the molecular weight of cartilage MGP is the same as bone MGP, and Northern blot analysis revealed that MGP mRNA from cartilage is the same size as the MGP mRNA from bone. The structurally related vitamin K-dependent protein bone Gla protein could not be detected in cartilage by radioimmunoassay or by Northern blot analysis. The discovery that MGP is synthesized by growth plate cartilage could provide an explanation for the excessive growth plate mineralization disorder seen in rats treated with the vitamin K antagonist warfarin and the punctate mineralization of the growth plate seen in infants whose mothers received warfarin in the first trimester of pregnancy (the fetal warfarin syndrome). Both disorders appear to be caused by the inactivation of a vitamin K-dependent mineralization inhibitor in cartilage, an inhibitor which we suggest is MGP.

(PDF same-day service: $19.90)

Accession: 006689466

Download citation: RISBibTeXText

PMID: 3258600

DOI: 10.1002/eji.1830180326



Related references

Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis and Rheumatism 41(12): 2143-2151, 1998

Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures. Arthritis and Rheumatism 60(12): 3676-3685, 2010

Cartilage oligomeric matrix protein (COMP): The role of a non-collagenous cartilage matrix protein as a marker of disease activity and joint destruction in RA- and OA-patients. Zeitschrift fuer Rheumatologie 58(2): 79-87, 1999

Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis. Zeitschrift für Rheumatologie 58(2): 79-87, 1999

Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: interaction, regulation and role in chondrogenesis. Matrix Biology 37: 102-111, 2015

The association of cartilage matrix protein with type ii collagen and chondroitin sulfate proteoglycan in the extracellular matrix of hyaline cartilage. Anatomical Record 229(4): 37A, 1991

Elevated Levels of Cartilage Oligomeric Matrix Protein during In Vitro Cartilage Matrix Generation Decrease Collagen Fibril Diameter. Cartilage 1(3): 200-210, 2010

Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors. Arthritis & Rheumatism 41(12): 2143-2151, 1998

Identification of a nuclear factor-I family protein-binding site in the silencer region of the cartilage matrix protein gene. Journal of Biological Chemistry 270(17): 10212-10221, 1995

Studies on ultrastructural identification and distribution of protein-polysaccharide in cartilage matrix. Journal of Cell Biology 32(2): 365-377, 1967

The distribution of cartilage oligomeric matrix protein (COMP) in equine carpal articular cartilage and its variation with exercise and cartilage deterioration. Veterinary Journal 162(2): 121-128, 2001

Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids. American Journal of Pathology 179(4): 1951-1960, 2012

Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. American Journal of Medical Genetics 80(5): 510-513, 1999

Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. American Journal of Medical Genetics 80(5): 510-513, 1998